Skip To Main Content
Jeffrey Kaiser on Muck Rack

Jeffrey Kaiser

San Francisco, Walnut Creek
As seen in: Nature, Frontiers, MDPI, Pediatrics, The Journal of Pediatrics
Experienced attorneys protecting consumers in defective pharmaceutical and product claims nationwide. Toll free: 855-534-0061

Get in touch with Jeffrey

Contact Jeffrey, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Jeffrey Kaiser’s Biography

Read Full Bio →

Jeffrey Kaiser has been litigating defective product claims for over 20 years nationwide. He is a veteran litigator who has argued appeals in both state and federal courts, and has handled numerous complex claims. He regularly handles cases involving mesothelioma, as well as defective pharmaceutical, medical devices, catastrophic injuries, and consumer class action cases. Widely regarded in legal circles for his skills and dedication, Jeff has won many victories, including multiple eight-figure…

Articles

A non-invasive diagnostic tool for the assessment of optimal positive-end expiratory pressure (PEEPOPT) in infants receiving prolonged invasive ventilation | Journal of Perinatology

|
By Nada Darwish, Ann Donnelly, Shaoyi Zhang, Dajiang J Liu, Jeffrey Kaiser, Roopa Siddaiah, Jennifer Erkinger
| Nature Verified
Abstract Establish the feasibility of optimizing PEEP (PEEPOPT) using ventilator software in infants receiving prolonged invasive mechanical ventilation. A retrospective review of infants who underwent PEEPOPT studies. Paired-t test was used to compare dynamic lung compliance (Cdyn), tidal volume (VT), and oxygen saturation (SpO2) before and after PEEPOPT studies.
Open in Who Shared Issue with article?

Proposed Screening for Congenital Hyperinsulinism in Newborns: Perspective from a Neonatal-Perinatal Medicine Group

|
By Jeffrey Kaiser, Shaili Amatya, Rebecca J. Burke, Tammy E. Corr
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Focusing on modifiable early protective factors to prevent negative neurodevelopmental and psychiatric outcomes in at-risk infants

|
By Cantonal Sociopsychiatric Organisation, Jeffrey Kaiser, Daniela Polese
| Frontiers
Introduction In the scientific debate, there is increasing awareness of the relevance of the first years of life as a basis for health and disease, as stated by the Developmental Origins of Health and Disease (DOHAD) hypothesis (1). Early at-risk conditions are determined by multiple potential genetic and environmental factors, as clearly exemplified by preterm birth.
Open in Who Shared Issue with article?
See all 11 articles